SmartTRAK identifies three orthopedic robotics companies strategically positioned to shake things up this year in the fast-growing robotic-assisted TJA market.

SmartTRAK projects robotic-assisted total knee arthroplasties (TKAs) will account for 48.5% of all US TKAs and 79.6% of all US robotic-assisted joint replacements by 2026E. This growth of robotic-assisted ortho procedures and ongoing adoption of enabling tech continues to drive the US ortho robotics market. In this Market Outlook Article, SmartTRAK identifies and analyzes three robotics companies that may shake things up in 2023 and beyond. They are:

• Stryker: Racing Towards New Indications in 2023
  • On the heels of a record-breaking quarter in Q422 in terms of MAKO installations in the US and internationally, market-leader Stryker (SYK) announced in its Q422 earnings call highly-anticipated timelines for the Company’s plans to launch ...
    
• THINK Surgical: Pursuing Two New Robots in 2023
  • THINK Surgical has a different approach compared to most robotics competitors. The Company focuses on providing robotic systems for joint replacement surgery, with an open implant library as an alternative to closed systems limited to a single manufacturer's implants. At the Canaccord Genuity Healthcare Conference in 2022, the Company revealed plans to ...
    
• Globus Medical: Bringing Knee Enabling Tech to Market in 2023
  • Since Globus Medical (GMED) acquired Stelkast in 2019 as a foundation for expanding into the total joint market, an orthopedic robotic system from the Company has been looming on the horizon. In the last two years, GMED has been consistently submitting intellectual property applications related to ...
    

To read the complete "Three Ortho Robotics Companies to Watch in 2023" Market Outlook article by By Shelly Caruso, SmartTRAK's Market Analyst/Medical Writer, Just click the button below.

• Strong Robotic Performance Despite Lackluster Revenue from Changing Deal Mix
• Expanding Robotic Applications Contribute to Growth
• Other Orthopedic Robotics Moving Forward
• Orthopedic Enabling Tech Making Inroads into Spine and Vice Versa
• Navigation Highlights
• Advances in Augmented Reality
• Preoperative Planning Highlights

Orthopedic robotics market leader SYK reported that Q422 was a record quarter for MAKO installations, both in the US and internationally, with an unsurpassed number of MAKO installations in ASCs. In Q422, SYK saw ...

Read the entire Q422 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q422 Extremities Market Recap* are:

• Complete Q422 Extremities Market Overview and Highlights
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• New Shoulder Products Driving Growth with More Tech Updates Coming
• Ankle Market Poised for Expansion with Next-Generation Implants and Technology
• Renewed Manufacturer Focus along with New Product Intros Fuel Upper Extremities Fixation
• Foot & Ankle Fixation Propelled by New Product Introductions
• Q422 Regulatory Highlights
  • Fixation
  • Shoulder Replacement
  • Elbow Replacement
  • Ankle Replacement
  • Toe Replacement
    

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Market Dynamics, Industry Moves and Technology Advancements 

In 2022, the Orthobiologics Market encountered both ups and downs. Though companies are still reporting year-end results, SmartTRAK feels the Orthobiologics Market finished on a high note. The 2022 challenges, such as staffing shortages at healthcare facilities, supply chain constraints and inflation, may cause headwind in 2023, stifling some growth.

Nevertheless, SmartTRAK anticipates the potential downsides will be offset by elective procedures returning to pre-COVID levels, along with progressive, transitional initiatives by select market players that have the potential to reshape certain orthobiologics segment landscapes.

Among the many topics covered in this Market Outlook article are:

• Reshaping the Competitive Landscape
• Shifts in the US Bone Replacement Market
• Advancements in Osteobiologics
• Shifts in the US Sports Medicine Market

In recent years, there have been significant advances in orthopedic treatments, surgical techniques and rehabilitation methods that have transformed the way we approach musculoskeletal disorders.SmartTRAK continues to report daily, in real-time on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.

SmartTRAK features curated content by our team of industry experts, bringing the most relevant information and insight directly to you in real-time. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos and interviews and Be The Expert.

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

• NuVasive*
  

  NUVA spoke about its upcoming product launches, including an expandable Lateral called MOD-EX XLIF and extended blade-fixation options for Modulus ALIF, and predicted that both will support the continued interest in NUVA. NUVA Q422 Earnings Transcripton Seeking Alpha

• Globus*

  GMED mgmt stated the ortho robot will launch w/ a knee application first w/ other applications to follow, noting it is unlikely that gap-filling joint implant systems would be launched prior to the knee application for robotics. GMED Q422 Earnings Transcript on Seeking Alpha

• CurvaFix Rodscrew* - CurvaFix

  CurvaFix announced a it will launch the 7.5 mm CurvaFix IM Implant, which received FDA clearance in Oct 2022, at this year’s AAOS annual meeting in Las Vegas. BusinessWire

Patents:

• SeaSpine*
  

  7D Surgical was granted US Patent “Systems And Methods For Intraoperative Spinal Level Verification” disclosing the use of segmented surface data from volumetic pt image data compared w/ intra-op surface data to verify spine levels w/o x-rays. 11564752

• Method for Treating Joint Pain  
  

  US Patent "Method for treating joint pain" was granted relating to treating joint pain by inserting a bone dowel and BMA into the subchondral of a bone and introducing BMA into the intra-articular space of the joint being treated. 11583402

Among the many topics covered in detail in this comprehensive article are:

Dr. Scott Sigman, founder and chief medical officer of OrthoLazer Orthopedic Laser Centers and host of the Ortho Show podcast, discusses current trends in arthroscopic sports medicine and orthopedic care in an in-depth interview with SmartTRAK.

In an interview with SmartTRAK, Scott Sigman, MD discusses many trends in arthroscopic technologies and soft tissue fixation including advancements in anterior cruciate ligament (ACL) repair with the BEAR Implant, graft selection in ACL reconstruction, the Stryker InSpace Balloon for massive rotator cuff tears, advancements in Latarjet, needle arthroscopy and more. Dr. Sigman is the chief medical officer and founder of OrthoLazer Orthopedic Laser Centers and the host of the Ortho Show podcast. 

To find out more about Dr. Sigman’s insights on sports medicine and arthroscopy, click on the following video to watch Andy Knapik, SmartTRAK's Sr. Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies, interview Dr. Sigman (49:55 min). A complete transcript of the interview is available here. For more details, interview topics by timecode are provided below.